These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35921699)
1. Discovery of potential active ingredients of Er-Zhi-Wan, a famous traditional Chinese formulation, in model rat serum for treating osteoporosis with kidney-yin deficiency by UPLC-Q/TOF-MS and molecular docking. Gao M; Xue X; Zhang X; Chang Y; Zhang Q; Li X; Wang Y; Zhang L; Li Z; Dong H; Wang W; Yao W J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123397. PubMed ID: 35921699 [TBL] [Abstract][Full Text] [Related]
2. Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine. Zhai Y; Xu J; Feng L; Liu Q; Yao W; Li H; Cao Y; Cheng F; Bao B; Zhang L J Ethnopharmacol; 2019 Apr; 234():57-66. PubMed ID: 30690072 [TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of kidney, bone and bone marrow explored potential mechanisms of Erzhi Wan against osteoporosis with kidney-Yin deficiency. Shang G; Zhou X; Yin J; Niu X; Zhao Y; Li X; Tong Q; Bao B; Cao Y; Cheng F; Li Z; Yao W J Pharm Biomed Anal; 2024 Aug; 246():116211. PubMed ID: 38759323 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of blood components of Yougui Yin in normal rats and rats with kidney deficiency caused by adenine based on UPLC-MS technology]. Shi YH; Yang H; Ran HF; Chen H; Zhang JF; Xue Q; Feng S; Xu XY Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2287-2297. PubMed ID: 34047132 [TBL] [Abstract][Full Text] [Related]
5. Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking. Li Y; Liu SS; Guo ZY; Yi H; Li C; Chen LM; Gao HM; Yan LH; Zhang WW; Feng XX; Zhao JY; Liu XQ; Wang ZM J Ethnopharmacol; 2021 Jul; 275():114045. PubMed ID: 33831463 [TBL] [Abstract][Full Text] [Related]
6. Screening and characterization of xenobiotics in rat bio-samples after oral administration of Shen-Wu-Yi-Shen tablet using UPLC-Q-TOF-MS/MS combined with a targeted and non-targeted strategy. Mei Y; Zhang X; Hu Y; Tong X; Liu W; Chen X; Cao L; Wang Z; Xiao W J Pharm Biomed Anal; 2023 Apr; 227():115286. PubMed ID: 36804290 [TBL] [Abstract][Full Text] [Related]
7. Exploration the mechanism of Shenling Baizhu San in the treatment of chronic obstructive pulmonary disease based on UPLC-Q-TOF-MS/MS, network pharmacology and in vitro experimental verification. Gao Z; Wang J; Lu G; Wu Q; Wang S; Wu X; Ou C; Wu Z; Yu H; Wang Y J Ethnopharmacol; 2024 Apr; 324():117728. PubMed ID: 38216101 [TBL] [Abstract][Full Text] [Related]
8. Screening of hypolipidemic active components in Jiang-Zhi-Ning and its preliminary mechanism research based on "active contribution value" study. Zhang Y; Li L; Zhang J; Lin T; Jiang Y; Liu B J Ethnopharmacol; 2021 May; 272():113926. PubMed ID: 33596472 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the potential curative effects of Gui-Zhi-Jia-Ge-Gen decoction on wind-cold type of common cold using multidimensional analysis. Wan X; Wu W; Zang Z; Li K; Naeem A; Zhu Y; Chen L; Zhong L; Zhu W; Guan Y J Ethnopharmacol; 2022 Nov; 298():115662. PubMed ID: 36031102 [TBL] [Abstract][Full Text] [Related]
10. Identification of multiple constituents in the traditional Chinese medicine formula Zhi-zi-chi decoction and rat plasma after oral administration by liquid chromatography coupled to quadrupole time-of-flight tandem mass spectrometry. Zhao X; Long Z; Dai J; Bi K; Chen X Rapid Commun Mass Spectrom; 2012 Oct; 26(20):2443-53. PubMed ID: 22976211 [TBL] [Abstract][Full Text] [Related]
11. HPLC/Q-TOF-MS-Based Identification of Absorbed Constituents and Their Metabolites in Rat Serum and Urine after Oral Administration of Cistanche deserticola Extract. Li WL; Sun XM; Song H; Ding JX; Bai J; Chen Q J Food Sci; 2015 Sep; 80(9):H2079-87. PubMed ID: 26243042 [TBL] [Abstract][Full Text] [Related]
12. Zuogui Wan alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction in newborn rats through Wnt/β-catenin signaling pathway. Chen L; Ren M; Cao J; Sang H; Chen H; Xu A; Zhao M J Ethnopharmacol; 2021 Oct; 279():114337. PubMed ID: 34146629 [TBL] [Abstract][Full Text] [Related]
13. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system. Cao X; Li H; Wang M; Ren X; Deng Y Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125 [TBL] [Abstract][Full Text] [Related]
14. Prediction of the mechanism of Dachengqi Decoction treating colorectal cancer based on the analysis method of " into serum components -action target-key pathway". Yin FT; Zhou XH; Kang SY; Li XH; Li J; Ullah I; Zhang AH; Sun H; Wang XJ J Ethnopharmacol; 2022 Jul; 293():115286. PubMed ID: 35413412 [TBL] [Abstract][Full Text] [Related]
15. UPLC-Q-TOF-MS(E) analysis of the constituents of Ding-Zhi-Xiao-Wan, a traditional Chinese antidepressant, in normal and depressive rats. Xu L; Mu LH; Peng J; Liu WW; Tan X; Li ZL; Wang DX; Liu P J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():36-42. PubMed ID: 26320983 [TBL] [Abstract][Full Text] [Related]
16. Identification of the absorbed components and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma by ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Zhu H; Bi K; Han F; Guan J; Zhang X; Mao X; Zhao L; Li Q; Hou X; Yin R J Pharm Biomed Anal; 2015; 111():277-87. PubMed ID: 25912849 [TBL] [Abstract][Full Text] [Related]
17. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification. Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014 [TBL] [Abstract][Full Text] [Related]
18. Metabolites profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry analysis. Geng JL; Dai Y; Yao ZH; Qin ZF; Wang XL; Qin L; Yao XS J Pharm Biomed Anal; 2014 Aug; 96():90-103. PubMed ID: 24731969 [TBL] [Abstract][Full Text] [Related]
19. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation. Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439 [TBL] [Abstract][Full Text] [Related]
20. High-throughput LC-MS method for the rapid characterization of multiple chemical constituents and metabolites of Da-Bu-Yin-Wan. Li X; Sun H; Zhang A; Liu Z; Zou D; Song Y; Liu L; Wang X J Sep Sci; 2017 Nov; 40(21):4102-4112. PubMed ID: 28841261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]